ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Direxion Daily Biotech Top 5 Bull 2X ETF
35.65
-1.3655
-3.69%
成交量:
265
成交额:
9,688
市值:
267.35万
市盈率:
- -
高:
35.65
开:
37.01
低:
35.65
收:
37.01
52周最高:
45.88
52周最低:
26.30
股本:
7.50万
流通股本:
7.50万
量比:
0.72
换手率:
0.35%
股息:
0.76
股息率:
2.14%
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
派拉蒙任命克雷兹为联合首席执行官 华纳兄弟并购交易临近完成
环球市场播报
·
10/01
临床试验显示,Regeneron的药物与诺和诺德的司美格鲁肽联用可将肌肉流失减少一半
路透中文
·
10/01
数据简报-大型制药公司纷纷转向中国寻求许可协议
路透中文
·
09/30
Ocular Therapeutix股价因竞争对手Kodiak在临床试验中获胜而暴跌,分析师称抛售反应过度
路透中文
·
09/29
数据简报-美国制药企业纷纷转向中国寻求许可协议
路透中文
·
09/28
科迪亚克科学公司股价上涨,因其眼部疾病药物达到临床试验目标
路透中文
·
09/28
美国食品药品监督管理局批准Mirum公司治疗罕见骨病的药物
路透中文
·
09/26
健康快讯:基因研究成果为逆转阿尔茨海默病脑损伤提供了线索
路透中文
·
09/25
安进一种自身免疫药物在后期临床试验达到主要目标
格隆汇
·
09/24
美国法官在夏威夷能源和解协议争议中主动回避
路透中文
·
09/24
2026中国制造业民营企业500强榜单发布,黑龙江两家企业上榜
黑龙江省工商联
·
09/23
美国研究综述-Allstate、Autozone、Vertex Pharmaceuticals
路透中文
·
09/23
安进(AMGN)股票9月22日盘中上涨3.90%:原因全解读
TradingKey中文
·
09/22
安进宣布Dazodalibep在干燥综合征III期试验中达到主要终点
投资观察
·
09/22
安进股价上涨,因其自身免疫疾病药物达到晚期临床试验目标
路透中文
·
09/22
Vertex股价上涨,因其肾病药物在中期研究中展现出良好前景
路透中文
·
09/22
数据简报-随着竞争日趋激烈,减肥药开发商纷纷抢占这一利润丰厚的市场
路透中文
·
09/22
安进股价盘前大涨逾4%,受第三期临床试验结果提振。
智通财经
·
09/22
福泰制药宣布Inaxaplin在特定AMKD患者群体中取得积极结果,第13周UACR显著降低42.7%
投资观察
·
09/22
安进宣布Dazodalibep治疗中重度系统性干燥综合征的3期临床试验取得积极顶线结果
美股速递
·
09/22
更多
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/TBXU/news?page=3"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":35.6468,"timestamp":1791921600000,"preClose":37.0123,"halted":0,"volume":265,"delay":0,"changeRate":-0.03689314092882648,"floatShares":75001,"shares":75001,"eps":0,"marketStatus":"未开盘","change":-1.3655,"latestTime":"10-13 16:00:00 EDT","open":37.0123,"high":35.6468,"low":35.6468,"amount":9688,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791964800000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":37.0123,"sharesOutstanding":100001,"nav":37.047,"aum":2778565.51,"dividendRate":0.021447,"bidAskSpread":0,"volumeRatio":0.715829},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":75001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.715829,"shares":75001,"dividePrice":0.76452,"high":35.6468,"amplitude":0,"preClose":37.0123,"low":35.6468,"week52Low":26.3,"pbRate":"--","week52High":45.88,"institutionHeld":0,"latestPrice":35.6468,"eps":0,"divideRate":0.021447,"volume":265,"delay":0,"ttmEps":0,"open":37.0123,"prevYearClose":31.065,"prevWeekClose":37.0564,"prevMonthClose":39.9,"prevQuarterClose":39.9,"fiveDayClose":37.0661,"twentyDayClose":38.289,"sixtyDayClose":33.1},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-09-22","symbol":"TBXU","amount":0.14204,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-22","defaultRemindTime":1790083800000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-29","payableDate":"2026-09-22","currency":"USD","dateTimestamp":1790049600000,"payDate":"2026-09-29"},{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"},{"executeDate":"2026-09-22","recordDate":"2026-09-22","paymentDate":"2026-09-29","value":0.14204,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:3,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672150738","title":"派拉蒙任命克雷兹为联合首席执行官 华纳兄弟并购交易临近完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2672150738","media":"环球市场播报","labels":["executive","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672150738?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 07:06","pubTimestamp":1790809560,"startTime":"0","endTime":"0","summary":"根据派拉蒙周三发布的一份声明,埃里森将继续担任该公司的董事长。此次任命只是派拉蒙预期中多项领导层变动之一。随着埃里森组建一支融合了华纳兄弟顶尖人才与克雷兹等资深高管的团队,他将负责管理这场复杂的合并交易。加州一名联邦法官签署了一项协议,解决了 12 位反对合并的州检察长提起的诉讼,从而为合并完成扫清了障碍。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-10-01/doc-initsier2223399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["FFSM","PRVT","TMED","IEFN","GTPE","MMID","UYG","XLFI","VXF","AAUM","MNA","PBPH","BK4561","WMG","IYH","BK4108","TBXU","CANC","ACTV","RSPH","PSP","DFMC","BK4585","BK4588","PEVC","RFG","BK4571","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672801517","title":"临床试验显示,Regeneron的药物与诺和诺德的司美格鲁肽联用可将肌肉流失减少一半","url":"https://stock-news.laohu8.com/highlight/detail?id=2672801517","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672801517?lang=zh_cn&edition=fundamental","pubTime":"2026-10-01 06:01","pubTimestamp":1790805704,"startTime":"0","endTime":"0","summary":"该公司表示,特雷沃格鲁马布单药治疗的安全性特征与司美格鲁肽相似,未出现意外副作用。Regeneron表示将不再推进该三联疗法。在试验的第一部分中,仅使用司美格鲁肽的患者在26周内瘦肌肉量减少了6.7%。与25毫克特雷沃格鲁马布联合使用时,肌肉量减少4.7%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4T45M1TF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU0109394709.USD","LU2362540622.SGD","LU0823434583.USD","TBXU","LU1974910355.USD","LU2468319806.SGD","LU0320765992.SGD","LU1917777945.USD","LU0058720904.USD","LU2106854487.HKD","LU2237438978.USD","LU2362541273.HKD","IBBQ","LU0289739699.SGD","LU0823434740.USD","LU0114720955.EUR","LU0823416689.USD","BK4139","LU2023250504.SGD","BK4585","LU2362541513.USD","IBB","BBH","LU0882574055.USD","LU0053666078.USD","BK4588","REGN","LU2324357040.USD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671620101","title":"数据简报-大型制药公司纷纷转向中国寻求许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2671620101","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671620101?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 20:19","pubTimestamp":1790770785,"startTime":"0","endTime":"0","summary":"数据简报-大型制药公司纷纷转向中国寻求许可协议修改发稿日期,重写导语和标题,并在全文中将欧洲制药商加入名单路透9月30日-诺和诺德NOVOb.CO周二表示,将向江苏恒瑞医药600276.SS支付最高26亿美元,以获得一种试验性减肥药的权益,这使其成为最新一家获得中国研发药物授权的制药企业。中国生物技术公司通常保留国内权益 ,并将药品授权至海外,以换取预付款、里程碑付款以及专利使用费。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL4T45M0ZE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1037948897.HKD","IE00B2B36J28.USD","IYH","IHE","BK4592","LU0149534421.HKD","LU1037948541.HKD","LU1571399168.USD","LU0689626769.HKD","LU2106854487.HKD","SG9999014542.SGD","LU2468319806.SGD","LU2324357040.USD","LU1061106388.HKD","IE00B1BXHZ80.USD","LU0098860793.USD","LU2097828557.USD","LU2242644610.SGD","LU2361044949.HKD","LU0321505868.SGD","SG9999014567.USD","LU1929549753.HKD","LU1064131003.USD","LU1069347547.HKD","SG9999014575.USD","LU1146622755.USD","SG9999001176.SGD","IE00B4R5TH58.HKD","LU2125154935.USD","IE0002141913.USD","BK1191","LU0130102774.USD","LU1997244956.HKD","LU2488822045.USD","IE00B3T34201.USD","LU1655091616.SGD","LU1941712348.USD","LU0289739343.SGD","LU0162691827.USD","LU2097828631.EUR","LU0070302665.USD","00013","LU0122379950.USD","LU0326950275.SGD","LU0463099449.HKD","LU1057294990.SGD","LU2125154778.USD","PPH","REGN","SG9999014559.SGD","LU0861579265.USD","GDOC","LU1781817850.SGD","LU0208291251.USD","XLV","LU1923622614.USD","LU0211331839.USD","LU1831875114.USD","LU0265550359.USD","LU1116320901.HKD","LU1580142542.USD","LU0823434740.USD","BK1589","IE00BFTCPJ56.SGD","LU2580892789.USD","03692","BK4588","LU0225284248.USD","LU2461242641.AUD","BK4581","LU0109394709.USD","IE000M9KFDE8.USD","LU2433249047.HKD","SG9999002224.SGD","LU2495084118.USD","LU2362540622.SGD","LU2097828805.USD","IE00BJT1NW94.SGD","IE00BLSP4452.SGD","LU0472753341.HKD","LU1066051498.USD","LU1883839398.USD","BK1588","SGXZ57979304.SGD","IE00B19Z3B42.SGD","SG9999011175.SGD","LU0225771236.USD","BBH","LU2361045086.USD","LU0477156953.USD","VHT","LU2089984988.USD","BK1583","LU0965509010.AUD","LU0965508806.USD","LU1291159041.SGD","LU0868494617.USD","LU1699723380.USD","FTXH","IE00BLSP4239.USD","LU2023250504.SGD","LU2362541513.USD","SG9999015358.SGD","BK1587","BK4568","LU0965509283.SGD","LU1255011170.USD","RXL","SG9999003800.SGD","LU1974910355.USD","LU1934455194.USD","KURE","LU1093756168.USD","LU0321505439.SGD","LU1188198961.HKD","LU0432979614.USD","LU0320765489.SGD","LU0985481810.HKD","LU1934455277.USD","BK4585","LU0053666078.USD","LU2357627491.SGD","LU0058720904.USD","LU0130517989.USD","IE0009355771.USD","LU2361044865.SGD","TRUH","LU2125909593.SGD","BK4516","LU0006306889.USD","LU0306806265.USD","LU1328615791.USD","LU2580892862.HKD","LU2596442595.SGD","LU2328871848.SGD","LU0985320562.USD","LU2148510915.USD","LU0456855351.SGD","LU1989771016.USD","LU0648001328.SGD","LU2112291526.USD","LU2491050071.SGD","LU2097828714.EUR","BK4559","IE00BN8TJ469.HKD","LU0942090050.USD","LU2491049909.HKD","HK0000165453.HKD","LU2125909247.SGD","BK4599","600276","IE00BBT3K403.USD","JDOC","LU0502904849.HKD","LU0868494708.USD","LU1032466523.USD","LU0859254822.USD","LU0203347892.USD","BK0196","LU1066051225.USD","BK4534","HRTS","LU0106261372.USD","TBXU","LU1035773651.USD","LU0289739699.SGD","LU0306807586.USD","BK4533","SG9999001176.USD","01276","BK0188","LU0405327494.USD","LU1917777945.USD","LU2097828474.EUR","LU0607220059.USD","IE00BJJMRZ35.SGD","LU1997245177.USD","IE00BSNM7G36.USD","SG9999002232.USD","BK4139","LU0823434583.USD","LU0114720955.EUR","LU1989772923.USD","01801","LU0170899867.USD","LU1430594728.SGD","LU1941712264.USD","LU0265550946.USD","LU0124676726.USD","LU0072461881.USD","SG9999013999.USD","BK0012","HCM","LU0965509101.SGD","LU0289961442.SGD","BK4550","LU1894683264.USD","LU0455707207.USD","LU2491050154.USD","LU0234572021.USD","LU1066053197.SGD","BK0183","BK0060","FHLC","IE0002270589.USD","MRK","LU2289578879.USD","PAWZ","LU0244354667.USD","SG9999001440.SGD","LU2237438978.USD","IBB","LU1064130708.USD","BMED","OZEM","LU0266013472.USD","LU0823416689.USD","LU1162221912.USD","LU1983299246.USD","SG9999015341.SGD","LU2362541273.HKD","LU0320765992.SGD","LU0238689110.USD","LU0511384066.AUD","BK4007","IE00B19Z3581.USD","BK0239","LU1934455863.HKD","LU1093756325.SGD","LU1585245621.USD","BK0028","IBBQ","IXJ","LU0057025933.USD","LU0889565916.HKD","LU2360032135.SGD","PFE","LU1116320737.USD","LU1894683348.USD","LU1201861249.SGD","LU1989772840.SGD","LU0405327148.USD","BK1161","LU1023059063.AUD","LU0320765646.SGD","LU1066051811.HKD","LU1820825898.SGD","LU1969619763.USD","LU0980610538.SGD","LU1997245094.SGD","LU2023250843.SGD","LU0203345920.USD","LU0069063385.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671252936","title":"Ocular Therapeutix股价因竞争对手Kodiak在临床试验中获胜而暴跌,分析师称抛售反应过度","url":"https://stock-news.laohu8.com/highlight/detail?id=2671252936","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671252936?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 02:37","pubTimestamp":1790620641,"startTime":"0","endTime":"0","summary":"BUZZ-Ocular Therapeutix股价因竞争对手Kodiak在临床试验中获胜而暴跌,分析师称抛售反应过度9月28日-** Ocular Therapeutix(OCUL.O)股价在午后交易中下跌18.8%,至7.84美元** Kodiak Sciences公司(KOD.O)的实验性药物Zenkuda和tabirafusp-ted在针对湿性年龄相关性黄斑变性患者的后期临床试验中达到了主要","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4S45K1CI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541273.HKD","BK4588","LU0320765992.SGD","LU2023250504.SGD","LU0058720904.USD","LU0823416689.USD","REGN","LU2089984988.USD","IBB","LU0823434583.USD","BK4505","LU0289739699.SGD","LU1974910355.USD","OCUL","BBH","IBBQ","BK4007","LU0114720955.EUR","LU0889565916.HKD","TBXU","LU0109394709.USD","LU2237438978.USD","LU0053666078.USD","BK4139","LU0882574055.USD","LU2468319806.SGD","LU2106854487.HKD","LU2362540622.SGD","LU0823434740.USD","KOD","LU1917777945.USD","BK4585","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670555622","title":"数据简报-美国制药企业纷纷转向中国寻求许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2670555622","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670555622?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 22:32","pubTimestamp":1790605948,"startTime":"0","endTime":"0","summary":"数据简报-美国制药企业纷纷转向中国寻求许可协议路透9月28日-默克公司周一同意向中国生物技术公司 SciBrunch Therapeutics支付4亿美元预付款,以获得一种实验性抗癌药的全球权益,成为最新一家获得中国研发药物授权的美国制药商。中国生物技术公司通常会保留国内权益 ,并将药物授权给海外企业,以此换取预付款、里程碑付款以及专利使用费。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4T45K134:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2133065610.SGD","LU1997245177.USD","LU0942090050.USD","LU0128525929.USD","LU0943347566.SGD","IE00B775H168.HKD","LU0868494708.USD","SGXZ51526630.SGD","SG9999013999.USD","LU0256863811.USD","LU1035775433.USD","LU0964807845.USD","LU0267386448.USD","09995","LU1814569148.SGD","LU0122379950.USD","LU2361045086.USD","LU2087625088.SGD","IE00BDGV0183.EUR","LU2125154778.USD","LU0170899867.USD","LU1979441026.SGD","LU0289961442.SGD","LU1585245621.USD","LU0174119429.USD","AGNG","LU1093756168.USD","LU2461242641.AUD","IE00B42XCP33.USD","LU0069063385.USD","LU1069347547.HKD","LU0708995401.HKD","BK4568","SMMT","VHT","LU0861579265.USD","LU2106854487.HKD","IE00BN29S564.USD","LU1883839398.USD","LU1116320737.USD","WDNA","IE0002141913.USD","IE00B543WZ88.USD","LU2063271972.USD","BK1593","LU1934455277.USD","LU1868837300.USD","CANC","LU2237438978.USD","LU2456880835.USD","XLV","BK0239","LU1280957306.USD","LU0455707207.USD","LU2097828474.EUR","LU1145028129.USD","LU0912757837.SGD","LU0061475181.USD","LU2468319806.SGD","IE00B7KXQ091.USD","LU0203345920.USD","SGXZ31699556.SGD","LU0607220059.USD","LU0648001328.SGD","LU0553294199.USD","LU1670711123.USD","LU0689472784.USD","LU2148510915.USD","LU0348767384.USD","SG9999015986.USD","LU1732800096.USD","LU0354030438.USD","LU1831875114.USD","LU0058720904.USD","LU0124676726.USD","LU1655091616.SGD","LU1629891620.HKD","IE0000B7K699.USD","LU1839511570.USD","LU1720051017.SGD","GB00BDT5M118.USD","TRUH","LU1328615791.USD","LU2361044865.SGD","LU1868836914.USD","LU1267930730.SGD","LU2237443978.SGD","LU1116320901.HKD","LU2746668461.USD","LU1989772840.SGD","LU0471298777.SGD","LU1983299246.USD","LU2023250504.SGD","LU0310799852.SGD","LU2111349929.HKD","LU1267930490.SGD","LU1997245094.SGD","LU2896262040.SGD","IXJ","SG9999015358.SGD","LU2399975544.HKD","LU1188198961.HKD","LU2023251221.USD","LU0949170772.SGD","LU2289578879.USD","LU0265550359.USD","BMED","BMY","IYH","SG9999011175.SGD","IE00BGHQF631.EUR","IE00BVYPNV92.GBP","BK4599","LU0320765646.SGD","LU1868836591.USD","LU0348735423.USD","LU2756315664.SGD","LU0787776722.HKD","LU2491050071.SGD","JDOC","LU0029864427.USD","LU1718418525.SGD","KURE","BBH","BK1574","LU1267930573.SGD","LU0738911758.USD","LU0561508036.HKD","RXL","THNR","600276","LU0820561818.USD","LU2476274308.USD","LU1236620834.HKD","LU2242652126.USD","LU0708994859.HKD","LU1066051498.USD","LU1244550221.USD","SG9999014542.SGD","LU0965509101.SGD","LU0109391861.USD","LU2361044949.HKD","LU1820825898.SGD","SG9999014567.USD","LU0820562030.AUD","LU0094547139.USD","FHLC","IE00BPRC5H50.USD","BK0183","IE00BFXG1179.USD","IE0004445239.USD","IE00BKDWB100.SGD","BK4559","LU1934455863.HKD","LU2756315318.SGD","LU1988902786.USD","IE00BBT3K403.USD","IE00BFSS7M15.SGD","LU1032466523.USD","LU2237443622.USD","LU2089283258.USD","LU0502904849.HKD","IE00B19Z3581.USD","LU2168564149.EUR","LU2491049909.HKD","LU0053666078.USD","IE00BN8TJ469.HKD","LU1961090484.USD","IE0009355771.USD","LU2097828805.USD","LU0306806265.USD","SGXZ57979304.SGD","BK0028","LU1244550577.SGD","BK4592","LU1934455194.USD","LU1929549753.HKD","LU2129689514.USD","LU1781817850.SGD","LU0795875169.SGD","IE000MB6IJN5.SGD","IE00BJT1NW94.SGD","LU1366192091.USD","TMED","LU2750360641.GBP","LU0417516902.SGD","LU2087621335.USD","ABBV","LU0868494617.USD","LU0320765059.SGD","BK4533","LU0316494557.USD","LU1691799644.USD","MHIP","IE000F7OJYX1.SGD","SG9999014575.USD","IE00B4R5TH58.HKD","LU2360106947.USD","BK4516","MRK","LLYZ","LU0985481810.HKD","01530","BK4581","SG9999014906.USD","LU0405327148.USD","LU0395794307.EUR","IE000WAW04H5.SGD","LU1023059063.AUD","LU2750360997.AUD","LU1670710661.SGD","LU0345770308.USD","LU1969619763.USD","LU1868837136.USD","LU1035773651.USD","LU2168564065.EUR","LU0348766576.USD","ELIS","LU0689626769.HKD","LU1732799900.SGD","LLY","SG9999015978.USD","LU2357627491.SGD","LU1670627923.USD","SG9999001176.USD","LU0980610538.SGD","LU0321505439.SGD","LU0289739343.SGD","LU1066051225.USD","LU1244550494.USD","LU0198837287.USD","LU1037948897.HKD","LU0405327494.USD","LU1670710588.SGD","LU0323591593.USD","IE00B1XK9C88.USD","LU0057025933.USD","LU1623119135.USD","HK0000165453.HKD","LU0149534421.HKD","LU1496350171.SGD","LU2580892862.HKD","LU0820561909.HKD","OZEM","IE00B1BXHZ80.USD","IE00B2B36J28.USD","LU1323610961.USD","LU1580142542.USD","SG9999002232.USD","BK1589","IE00BJJMRZ35.SGD","LU0353189763.USD","HRTS","LU0683600562.USD","LU2237443465.HKD","MEDI","PPH","LU1804176565.USD","LU0225771236.USD","IE00BKPKM429.USD","LU1670628061.USD","CURE","LU1868836757.USD","LU0320765992.SGD","LU0882574055.USD","LU1064130708.USD","LU2237443382.USD","LU2552382215.SGD","LU2023250843.SGD","LU0203347892.USD","LU0321505868.SGD","LU1941712264.USD","LU1997244956.HKD","LU0133085943.USD","GLAM","IE000M9KFDE8.USD","LU0795875086.SGD","BK4588","LU0417516571.SGD","LU2097828714.EUR","LU0306807586.USD","LU0417517546.SGD","BK4534","LU1003077747.HKD","LU1430594728.SGD","LU2125154935.USD","IE00BLSP4239.USD","LU0417516738.SGD","LU0385154629.USD","LU0859254822.USD","LU0266013472.USD","LU2462591350.SGD","LU0208291251.USD","IE00BK4W5L77.USD","SG9999001176.SGD","LU2360032135.SGD","SG9999015945.SGD","LU0098860793.USD","LU1066053197.SGD","LU2097828557.USD","LU2168564222.USD","LU0540923850.HKD","GDOC","IE00BLSP4452.SGD","LU0210536198.USD","IE0001KFT4U8.USD","BK4566","LU1894683348.USD","LU1720050803.USD","LU0348783233.USD","LU0114720955.EUR","LU1894683264.USD","LU1941712348.USD","BK0188","BK4585","LU2242644610.SGD","LU2462157665.USD","LU0726765562.USD","IBBQ","LU2476274720.SGD","LU2552382058.USD","LU0211331839.USD","LU0211327993.USD","LU1127390331.HKD","LU2089284900.SGD","SG9999003800.SGD","SG9999014914.USD","LU1923622614.USD","BK4550","LU0106261372.USD","LU1551013342.USD","LU2264538146.SGD","SG9999014898.SGD","SG9999018865.SGD","LU2125909247.SGD","BK1583","SG9999015952.SGD","LU2746668974.SGD","LU0097036916.USD","LU2236285917.USD","BK4007","LU0238689110.USD","LU0466842654.USD","IE00BWXC8680.SGD","LU2168564495.EUR","LLYX","BK0012","LU0158827781.USD","LU2112291526.USD","BK0060","SG9999015341.SGD","IE00BJLML261.HKD","LU2347655156.SGD","IE00BVYPNW00.USD","LU0640476718.USD","SG9999018857.SGD","MEDX","LU1496350502.SGD","LU2211815571.USD","PJP","LU0965509010.AUD","LU0203201768.USD","LU1989772923.USD","LU0965508806.USD","LU0234572021.USD","LU1699723380.USD","LU0072461881.USD","LU0158827948.USD","LU1093756325.SGD","LU0354030511.USD","LU1064131003.USD","LU2023250330.USD","LU2552382132.HKD","LU1670711040.USD","IE00B3T34201.USD","LU0326950275.SGD","LU0432979614.USD","LU1074936037.SGD","ELIL","LU0672654240.SGD","LU0234570918.USD","LU0477156953.USD","LU2108987350.USD","SG9999001440.SGD","LU0162691827.USD","LU0545039389.USD","LU0985320562.USD","LU0130517989.USD","LU2471134796.USD","IE00B3PB1722.GBP","REGN","LU1712237335.SGD","LU2580892789.USD","LU2471134523.USD","LU0345770993.USD","LU1236620750.USD","IE000BZT7R73.USD","LU2596442595.SGD","LU2237443895.HKD","LU2265009873.SGD","LU2237443549.SGD","LU0661504455.SGD","IE0002270589.USD","LU0634319403.HKD","BK0196","IBB","SGXZ81514606.USD","LU2495084118.USD","LU2471134879.HKD","PFE","IE0005OL40V9.USD","LU1291159041.SGD","LU0130102774.USD","01801","LU2417539215.USD","IE00BJJMRX11.SGD","LU1037948541.HKD","LU2168563687.JPY","LU0289739699.SGD","LU0456855351.SGD","LU1794554557.SGD","IE0004445015.USD","TBXU","LU1069344957.HKD","BK4532","ILDR","LU0225283273.USD","LU0225284248.USD","LU0320765489.SGD","LU1064131342.USD","LU1061106388.HKD","LU0348827113.USD","LU1720051108.HKD","LU2328871848.SGD","LU0823416689.USD","LU2125909593.SGD","LU0823434740.USD","FTXH","LU2089984988.USD","LU0823434583.USD","LU0463099449.HKD","SG9999017495.SGD","LU2362541273.HKD","LU2778985437.USD","LU1255011170.USD","BK1191","LU1201861249.SGD","LU0096364046.USD","LU2602419157.SGD","09926","LU2491050154.USD","LU0310800379.SGD","LU1232071149.USD","LU2028103732.USD","03692","688331","LU0472753341.HKD","LU2362540622.SGD","LU2213496289.HKD","LU2097828631.EUR","LU0511384066.AUD","LU0348825331.USD","IE00BFTCPJ56.SGD","LU1066051811.HKD","LU0109394709.USD","LU1974910355.USD","LU2347655073.USD","IE00B19Z3B42.SGD","IE00B5MMRT66.SGD","LU2488822045.USD","BK1161","LU1548497426.USD","SG9999014559.SGD","LU0070302665.USD","LU0244354667.USD","LU2357305700.SGD","LU2362541513.USD","IE00BJJMRY28.SGD","LU0348784397.USD","LU1146622755.USD","LU0965509283.SGD","IE000SO60NU8.SGD","LU2242646821.SGD","IHE","LU0237698245.USD","LU0203202063.USD","IE00BFSS8Q28.SGD","LU0889565916.HKD","LU1989771016.USD","IE00BK4W5M84.HKD","LU0211328371.USD","LU0882574139.USD","LU1571399168.USD","LU2271345857.HKD","LU0786609619.USD","LU2129689431.USD","LU2433249047.HKD","LU0353189680.USD","LU0265550946.USD","IE00BSNM7G36.USD","LLII","LU0079474960.USD","LU1057294990.SGD","LU2324357040.USD","PAWZ","BK4139","LU1162221912.USD","LU0256863902.USD","IE00B4JS1V06.HKD","01276","LU2129689605.HKD","SG9999002224.SGD","LU0006306889.USD","LU1551013425.SGD","SG9999014880.SGD","LU1261432733.SGD","LU2471134952.CNY","LU1917777945.USD","LU0471298694.HKD","SGXZ99366536.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670399962","title":"科迪亚克科学公司股价上涨,因其眼部疾病药物达到临床试验目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2670399962","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670399962?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 18:50","pubTimestamp":1790592647,"startTime":"0","endTime":"0","summary":"BUZZ-科迪亚克科学公司股价上涨,因其眼部疾病药物达到临床试验目标9月28日-** 制药公司科迪亚克科学(Kodiak Sciences,股票代码:KOD.O)的股价在盘前交易中上涨43.9%,至46.56美元** 该公司表示,其实验性药物Zenkuda和tabirafusp-ted在针对湿性年龄相关性黄斑变性患者开展的晚期临床试验中达到了主要目标** 这两种药物在一年时均实现了视力改善,其效果","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4T45K0PI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2106854487.HKD","IBB","LU0823416689.USD","LU0823434740.USD","BBH","LU1917777945.USD","KOD","LU2362541273.HKD","LU0114720955.EUR","LU0109394709.USD","LU2089984988.USD","LU2362540622.SGD","LU0053666078.USD","LU2468319806.SGD","LU2362541513.USD","TBXU","BK4588","LU0058720904.USD","LU0289739699.SGD","IBBQ","LU2023250504.SGD","LU0889565916.HKD","LU0320765992.SGD","REGN","BK4505","BK4585","LU2237438978.USD","LU0823434583.USD","BK4139","LU1974910355.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670421598","title":"美国食品药品监督管理局批准Mirum公司治疗罕见骨病的药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2670421598","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670421598?lang=zh_cn&edition=fundamental","pubTime":"2026-09-26 02:57","pubTimestamp":1790362678,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局批准Mirum公司治疗罕见骨病的药物路透9月25日-美国食品药品监督管理局周五表示,已批准米鲁姆制药公司(Mirum Pharmaceuticals)的MIRM.O药物用于治疗一种罕见骨病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260925:nL4T45H12U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823434740.USD","LU1917777945.USD","LU2237438978.USD","LU2362541513.USD","MIRM","LU2106854487.HKD","LU2089984988.USD","BK4585","BK4588","LU2362541273.HKD","LU0889565916.HKD","REGN","BBH","LU0109394709.USD","LU1974910355.USD","INCY","LU0053666078.USD","LU0823434583.USD","IBBQ","LU0114720955.EUR","LU2468319806.SGD","IBB","LU2023250504.SGD","LU2362540622.SGD","IDNA","BK4532","BK4139","BK4550","LU0289739699.SGD","LU0320765992.SGD","LU0823416689.USD","LU0882574055.USD","LU0058720904.USD","TBXU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670824413","title":"健康快讯:基因研究成果为逆转阿尔茨海默病脑损伤提供了线索","url":"https://stock-news.laohu8.com/highlight/detail?id=2670824413","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670824413?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 04:51","pubTimestamp":1790283102,"startTime":"0","endTime":"0","summary":"健康快讯:基因研究成果为逆转阿尔茨海默病脑损伤提供了线索《Health Rounds》荣获2026年出版商通讯奖“最佳科学通讯”奖,每周二和周四发布。阿尔茨海默病相关基因的影响或可逆转研究阿尔茨海默病最强遗传风险因素的科学家表示,他们发现了关于该基因作用机制的新线索,并指出其对大脑的损害效应或许有可能被逆转。I期临床试验旨在评估安全性而非疗效,因此这一令人鼓舞的结果尚需通过更大规模的试验予以证实。该研究以小鼠细胞为对象。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260924:nL4T45G1QV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","LU0114720955.EUR","BBH","LU0122379950.USD","LU1023059063.AUD","LU1430594728.SGD","LU1066053197.SGD","LU1934455863.HKD","LU0965509010.AUD","LU0889565916.HKD","SG9999015986.USD","LU0234570918.USD","BK4532","IE00BZ1G4Q59.USD","LU1571399168.USD","LU1057294990.SGD","LU2468319806.SGD","BIB","BK4588","LU1061106388.HKD","LU0965508806.USD","LU0289739699.SGD","LU1066051498.USD","IE00B19Z3B42.SGD","LU1934455277.USD","LU2087621335.USD","BMED","LU0861579265.USD","LU0320765992.SGD","SG9999015945.SGD","IE0002270589.USD","LU1674673691.USD","BK4566","SG9999015952.SGD","LU0965509283.SGD","TMED","IBB","TBXU","MEDI","BK4583","IE00B7SZLL34.SGD","BK4578","LU1934455194.USD","LU0823416689.USD","LU1674673428.USD","LU1778281490.HKD","IE00B3T34201.USD","IBBQ","SG9999015978.USD","LU0965509101.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669453169","title":"安进一种自身免疫药物在后期临床试验达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2669453169","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669453169?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 10:32","pubTimestamp":1790217159,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B4R5TH58.HKD","SG9999001440.SGD","LU2112291526.USD","LU1571399168.USD","MDTX","LU0889565916.HKD","BK4566","BBH","BK4139","BK4599","BK4534","LU0320765992.SGD","PBE","LU0058720904.USD","LU1061106388.HKD","PSYK","IE00BJJMRZ35.SGD","LU1057294990.SGD","BK4581","IE0009355771.USD","AMGN","IE00B2B36J28.USD","LU2089984988.USD","BIB","IE00BJT1NW94.SGD","LU1983299246.USD","BMED","PJP","LU2242646821.SGD","IE0002141913.USD","LU0122379950.USD","BK4533","IBB","TBXU","IBBQ","LU2242652126.USD","BK4588","IBBJ","BK4585","LU0868494617.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1023059063.AUD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669643959","title":"美国法官在夏威夷能源和解协议争议中主动回避","url":"https://stock-news.laohu8.com/highlight/detail?id=2669643959","media":"路透中文","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669643959?lang=zh_cn&edition=fundamental","pubTime":"2026-09-24 05:01","pubTimestamp":1790197315,"startTime":"0","endTime":"0","summary":"美国法官在夏威夷能源和解协议争议中主动回避法官表示,他及其家人可能受此前和解协议的保护法院委员会向该法官提供了伦理指导一名来自俄勒冈州的法官被指定主持该诉讼Mike Scarcella路透9月23日-夏威夷一名联邦法官已主动回避审理一起争议案件,该案涉及数十年前达成的价格垄断和解协议是否阻止该州就气候变化问题起诉雪佛龙及其他能源公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL4S45F1FO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FENY","IE00BZ1G4Q59.USD","CVX","ERX","LU0109394709.USD","GILD","GXPE","TRUN","LU1929549753.HKD","LU2168564149.EUR","LU1430597077.USD","FTXN","LU0942090050.USD","IBB","BBH","BMED","LU0868494708.USD","DIG","LU1162221912.USD","LU1032466523.USD","LU0320765992.SGD","DRLL","BK4534","TEXU","LU1934455863.HKD","TBXU","IYE","LU0070302665.USD","IBBQ","LU0965509283.SGD","LU1674673428.USD","LU0640476718.USD","IGE","WEEI","LU0149725797.USD","XLE","LU0630314457.HKD","TMED","IXC","LU2133065610.SGD","MEDI","LU0265550359.USD","BIB","IE00B2Q91V27.USD","LU0114720955.EUR","LU0256331488.USD","LU0788109394.HKD","LU2357627491.SGD","LU0345780950.USD","VDE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669485558","title":"2026中国制造业民营企业500强榜单发布,黑龙江两家企业上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2669485558","media":"黑龙江省工商联","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669485558?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 19:47","pubTimestamp":1790164020,"startTime":"0","endTime":"0","summary":"9月22日全国工商联发布“2026中国制造业民营企业500强”榜单黑龙江共有两家企业入选黑龙江飞鹤乳业有限公司黑龙江鸿展生物科技股份有限公司","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-23/doc-inisvqcx5241743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1597","BK1553","06186","BIOY","TBXU","BK1589","BK1237","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669059271","title":"美国研究综述-Allstate、Autozone、Vertex Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2669059271","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669059271?lang=zh_cn&edition=fundamental","pubTime":"2026-09-23 15:38","pubTimestamp":1790149088,"startTime":"0","endTime":"0","summary":"美国研究综述-Allstate、Autozone、Vertex Pharmaceuticals路透9月23日-周三,华尔街证券分析师调整了多家在美国上市公司的评级和目标股价,其中包括Allstate、Autozone和Vertex Pharmaceuticals。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL4S45F0H4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU1917777945.USD","LU2458330243.SGD","LU0072461881.USD","LU0786609619.USD","LU1069344957.HKD","FXL","LU0823416689.USD","BK4585","IE000SO60NU8.SGD","BK4532","IE00BMPRXN33.USD","LU0098860793.USD","LU0070302665.USD","LU0079474960.USD","LU2065732104.USD","BK4139","LU1119994496.HKD","LU2456880835.USD","LU2362540622.SGD","LU2098885051.SGD","IYH","LU1235294995.USD","IE00BZ9MQY76.HKD","LU1221951046.USD","IE000BZT7R73.USD","LU1066051811.HKD","LU0476273544.USD","LU2322448957.HKD","AIS","IE0002141913.USD","LU0320765489.SGD","SG9999002224.SGD","LU0689626769.HKD","IE00B2B36J28.USD","LU1046421795.USD","LU0130102774.USD","LU1923622614.USD","BK4604","LU1989764664.SGD","LU2362541513.USD","LU0861579265.USD","LU0511384066.AUD","ANAB","IE00B4R5TH58.HKD","SMTC","BK4599","LU0058720904.USD","LU2357305700.SGD","LU0642271901.SGD","LU0477156953.USD","LU2236285917.USD","LU0859254822.USD","LU2089985449.USD","LU1861220033.SGD","04332","BK4567","LU2125154935.USD","AIFD","BK4214","IE0004091025.USD","IE00BLSP4239.USD","ARTY","IE00BJT1NW94.SGD","LU0471298777.SGD","LU2360106947.USD","LU0130517989.USD","IE00B775SV38.USD","LU0823421333.USD","LU2473716301.USD","LU0234572021.USD","IE0000B7K699.USD","LU0053666078.USD","LU2468319806.SGD","LU0432979614.USD","HRTS","BK4007","IE00B19Z9P08.USD","LU1585245621.USD","DCH","LU0006306889.USD","LU2463526074.USD","BK4097","LU0965509101.SGD","THNR","LU2298322129.HKD","LU1854104046.USD","LU0889565916.HKD","LU0289739343.SGD","MVLL","LU2324357040.USD","IE0002270589.USD","PAWZ","LU2506951958.HKD","SOXY","BK4533","MADE","LU1506573853.SGD","LU2125154778.USD","LU2506952170.USD","LU1934455194.USD","BK4512","IE000F7OJYX1.SGD","IE00BBT3K403.USD","BK4550","LU1035773651.USD","LU1316542783.SGD","IE00BMPRXR70.SGD","LU0823421416.USD","SG9999000418.SGD","LU2242646821.SGD","LU2361044865.SGD","LU1066051498.USD","LU0205194284.USD","BK4517","LU0106261612.USD","FAI","DTCR","LU2322448791.USD","LU0965509283.SGD","SG9999014575.USD","LU1169589451.USD","LU1201861249.SGD","PATH","FTXH","BK4551","LU1989764748.USD","LU0980610538.SGD","LU0274383776.USD","FDTX","BK4547","LU0300736062.USD","SITX","LU1854103824.USD","IE00B3S45H60.SGD","LU0345770993.USD","LU1878469433.USD","LU0985320562.USD","LU0203345920.USD","BK4128","LU1057294990.SGD","BK4559","LU0056508442.USD","LU1093756325.SGD","WUGI","LU0471298694.HKD","LU2360107168.USD","BK4149","LU2458330169.SGD","LU2041044095.USD","PATX","LU0348723411.USD","MRVX","LU2491050154.USD","SG9999013999.USD","LU1721429402.USD","LU1934455277.USD","LU2361044949.HKD","BK4515","LU1162221912.USD","SITM","LU0823434740.USD","LU1674673691.USD","LU0472753341.HKD","GRDN","MRK","BSVN","BK4136","KBH","LU0012050646.USD","CLDX","LU0300736492.USD","MRVU","LU0868494708.USD","LU1861215975.USD","LU0289739699.SGD","BK4141","LU2433249047.HKD","AZO","LU1815336760.USD","LU1116320901.HKD","GPK","LU2272731600.USD","LU0266013472.USD","LU2272731865.HKD","SG9999001176.USD","LU1066053197.SGD","LU0057025933.USD","IE00BZ199S13.USD","LU2360108059.USD","LU1559883803.SGD","BK4543","ANIX","LU1929549753.HKD","LU2244417387.USD","SMTG","BK4505","LU2491050071.SGD","LU0265550359.USD","VRTX","LU2125909247.SGD","LU1032466523.USD","ON","PBE","LU0965509010.AUD","LU2360107325.USD","LU1978683503.SGD","LU2361045086.USD","LU2125909593.SGD","IDNA","LU0081259029.USD","LU0162691827.USD","LU2417539215.USD","LU1861558580.USD","SG9999014567.USD","LU2543165471.USD","IBBQ","BMED","LU0187121727.USD","LU1992135399.USD","CMPX","XNTK","LU1291159041.SGD","LU0124384867.USD","LU2360032135.SGD","BK4196","LU1699723380.USD","IE00B1BXHZ80.USD","ACHC","LU1989772840.SGD","BK4588","LU1032955483.USD","IAK","LU1571399168.USD","SG9999015358.SGD","IE00B894F039.SGD","PKB","LU2491049909.HKD","LU2106854487.HKD","LU1116320737.USD","BK4566","LU2355687059.USD","GDOC","LU0385154629.USD","LU1720051108.HKD","BK4124","LU0106261372.USD","LU0724618433.USD","LU0154245756.USD","LU1548497426.USD","LU2506952097.USD","BK4539","THO","BK4561","LU0203347892.USD","LU2089984988.USD","LU1941712348.USD","BBH","JDOC","BIB","LU1037948897.HKD","LU1721429741.USD","FHLC","LU2380233275.USD","LU1196500208.SGD","LU0965508806.USD","LU2112291526.USD","LU1430594728.SGD","IE00BD6J9T35.USD","LU1169590202.USD","QQQA","BK4142","TBXU","LU0823417653.USD","LU0109394709.USD","LU0314106906.USD","LU1852331112.SGD","LU1061106388.HKD","SG9999001077.SGD","BK4011","AMGN","BK4099","LU1303367103.USD","SG9999001440.SGD","LU1989771016.USD","LU2272731782.SGD","LU1093756168.USD","IE00BSNM7G36.USD","IE0004086264.USD","LU0238689110.USD","LU2462157665.USD","LU0122379950.USD","SG9999014542.SGD","BK4548","LU0566484027.USD","LU1674673428.USD","LU0823434583.USD","CMI","IE00B19Z3B42.SGD","LU0320765646.SGD","LU1642822529.SGD","LU2023250504.SGD","MRVL","CCL","XLV","LU1983260115.SGD","OZEM","FTXL","ONG","BK4107","LU1778281490.HKD","IE00BLSP4452.SGD","LU0963586101.USD","BK4516","LU0320765992.SGD","LU2461242641.AUD","LU0345770308.USD","IE00BJJMRZ35.SGD","LU2092937221.SGD","IE000MB6IJN5.SGD","LU1861219969.SGD","LU0069063385.USD","MLM","LU1261432733.SGD","LU2362541273.HKD","LU1066051225.USD","LU1035775433.USD","LU2357627491.SGD","LU0061475181.USD","LU0942090050.USD","LU0868494617.USD","ONX","TRUH","LU0648001328.SGD","LU0256863811.USD","LU1861214812.USD","LU2290526834.HKD","SG9999014559.SGD","LU1720051017.SGD","RXL","SG9999015341.SGD","ALL","LU0417517546.SGD","LU1974910355.USD","PJP","LU1934455863.HKD","LU1941712264.USD","SG9999001176.SGD","IE00BN8TJ469.HKD","GNMX","IE00BFMHRM44.USD","GTEK","LU0823417737.USD","LU0950375773.USD","LU0957808578.USD","LU1989772923.USD","IE000WAW04H5.SGD","LU0154245673.USD","IE000M9KFDE8.USD","LU0444971666.USD","LU1084165304.USD","LU2023250843.SGD","LU1861559042.SGD","LU0127658192.USD","BK4211","IHE","IE00BMPRXQ63.HKD","BK4088","LU0444973449.USD","VMC","PPH","LU2298321311.HKD","LU0124676726.USD","LU2242652126.USD","BK4581","SGXZ57979304.SGD","XHB","VKTX","LU0208291251.USD","IE00B19Z9Z06.USD","IBB","LU1023059063.AUD","LU2237438978.USD","LU1992135472.HKD","LU0234570918.USD","LU1221951129.SGD","LU1069347547.HKD","LU0289961442.SGD","SMHX","LU2506951875.HKD","LU0205193047.USD","LU1823568750.SGD","VHT","IXJ","LU0154236417.USD","LU1983299246.USD","IE00B19Z3581.USD","LU2931357623.SGD","SG9999002232.USD","LU0265550946.USD","LU0211331839.USD","BK4534","LU1037948541.HKD","BK4185","IE00BFTCPJ56.SGD","BK4605"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669182123","title":"安进(AMGN)股票9月22日盘中上涨3.90%:原因全解读","url":"https://stock-news.laohu8.com/highlight/detail?id=2669182123","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669182123?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 23:16","pubTimestamp":1790090164,"startTime":"0","endTime":"0","summary":"• 在 dazodalibep 的 3 期 OASIZ 301 试验取得积极结果后,安进股价上涨。\n• 公司公布的年营收为 367.5 亿美元,净利润为 77.1 亿美元。\n• 分析师给出的平均目标价为 389.14 美元,评级为“持有”。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262180817-market-movers-amgn-20260922","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999001440.SGD","BK4585","AMGN","BK4534","LU1023059063.AUD","LU0122379950.USD","TBXU","IE00BJT1NW94.SGD","BK4588","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IBB","BK4599","LU2468319806.SGD","LU1983299246.USD","LU2242646821.SGD","LU1061106388.HKD","LU2089984988.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","PJP","IE0009355771.USD","PBE","BBH","LU2112291526.USD","LU1057294990.SGD","LU0889565916.HKD","LU0289739699.SGD","BK4533","LU0868494617.USD","LU0109394709.USD","BK4581","LU0320765992.SGD","LU1571399168.USD","BK4566","LU2242652126.USD","BK4139","LU0058720904.USD","IE00BJJMRZ35.SGD","IBBQ","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121969920","title":"安进宣布Dazodalibep在干燥综合征III期试验中达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1121969920","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121969920?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:50","pubTimestamp":1790085037,"startTime":"0","endTime":"0","summary":"路透社9月22日消息——安进公司(Amgen Inc)于近日披露其关键临床进展:\n安进旗下药物Dazodalibep在针对中重度症状性干燥综合征的III期OASIZ 303研究中,成功达到主要终点,该项试验预计将于2026年第四季度完成。\n安进表示,Dazodalibep在III期干燥综合征试验中取得主要终点的积极结果,该药物在系统性疾活动度方面展现出具有统计学显著性及临床意义的改善。\n值得注意的是,这一进展为干燥综合征患者群体带来了新的治疗希望。安进公司股票代码为AMGN.O。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","LU0109394709.USD","BK4139","IBBQ","LU1571399168.USD","LU0058720904.USD","BK4533","LU1983299246.USD","SG9999001440.SGD","LU0868494617.USD","BK4566","IE00B2B36J28.USD","BK4534","LU0889565916.HKD","PJP","LU1061106388.HKD","LU2242652126.USD","BK4585","IE0002141913.USD","LU2089984988.USD","TBXU","AMGN","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU1023059063.AUD","LU2112291526.USD","LU2468319806.SGD","BK4588","LU0289739699.SGD","BBH","IE0009355771.USD","IE00BJJMRZ35.SGD","IBB","LU0122379950.USD","LU1057294990.SGD","LU2242646821.SGD","BK4581","PBE","LU0320765992.SGD","IE00B4R5TH58.HKD","BIB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669019147","title":"安进股价上涨,因其自身免疫疾病药物达到晚期临床试验目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2669019147","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669019147?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:48","pubTimestamp":1790084914,"startTime":"0","endTime":"0","summary":"BUZZ-安进股价上涨,因其自身免疫疾病药物达到晚期临床试验目标9月22日-** 制药公司安进(Amgen)AMGN.O的股价上涨2.4%,至402.69美元** 该公司表示,其用于治疗舍格伦综合征的实验性药物达佐达利贝普(dazodalibep)在后期临床试验中达到了降低疾病活动度的主要目标 (link)** 舍格伦综合征是一种自身免疫性疾病,会导致眼睛、口腔及身体其他部位干燥,并伴有疲劳和慢性疼痛** 该药物在第48周时显示出具有统计学意义且临床意义显著的改善;大多数副作用为轻度至中度** 该公司计划在即将举行的医学会议上公布详细结果** 计入本次交易,AMGN今年以来累计上涨23.1%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4T45E0WT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4534","BBH","IBBQ","IE00B2B36J28.USD","LU2242646821.SGD","LU0122379950.USD","PBE","BK4139","IE00BJJMRZ35.SGD","LU2112291526.USD","IBB","BK4588","LU1061106388.HKD","SG9999001440.SGD","TBXU","IE0002141913.USD","LU0320765992.SGD","BK4585","LU0889565916.HKD","LU0058720904.USD","LU2242652126.USD","BK4581","PJP","IE0009355771.USD","BK4599","BIB","LU1571399168.USD","LU1983299246.USD","LU0868494617.USD","LU1023059063.AUD","LU2089984988.USD","LU0289739699.SGD","LU2468319806.SGD","LU1057294990.SGD","BK4566","IE00B4R5TH58.HKD","AMGN","BK4533","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147201","title":"Vertex股价上涨,因其肾病药物在中期研究中展现出良好前景","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147201","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147201?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:40","pubTimestamp":1790084435,"startTime":"0","endTime":"0","summary":"BUZZ-Vertex股价上涨,因其肾病药物在中期研究中展现出良好前景9月22日-** Vertex Pharmaceuticals(VRTX.O)股价上涨1.1%,至516.53美元** 这家生物技术公司表示,其试验性药物 inaxaplin 在治疗 APOL1 介导的肾病患者 13 周后,使尿液中蛋白质含量(肾损伤的关键指标)降低了 42.7%** 这种遗传性肾脏疾病主要影响非洲裔人群,可能导","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4T45E0WL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0256863811.USD","LU2362541513.USD","IE00BJT1NW94.SGD","LU1035775433.USD","IBBQ","GNMX","PBE","IE00B19Z3581.USD","IE00B894F039.SGD","LU1093756325.SGD","IE00B19Z9P08.USD","BIB","BBH","LU2362541273.HKD","LU2089984988.USD","IBB","IE00BZ9MQY76.HKD","LU2456880835.USD","IE0002270589.USD","IE00B2B36J28.USD","LU1093756168.USD","LU1069344957.HKD","BK4588","LU2236285917.USD","LU0417517546.SGD","IE00B19Z3B42.SGD","IE0009355771.USD","IE00B19Z9Z06.USD","LU1674673428.USD","VRTX","LU0432979614.USD","LU2324357040.USD","LU1430594728.SGD","BK4532","IE00B4R5TH58.HKD","LU2362540622.SGD","BK4533","BK4585","BK4567","SG9999001176.SGD","LU1778281490.HKD","SG9999001176.USD","SGXZ57979304.SGD","LU2462157665.USD","LU2237438978.USD","LU0061475181.USD","TBXU","LU0889565916.HKD","SG9999013999.USD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142742","title":"数据简报-随着竞争日趋激烈,减肥药开发商纷纷抢占这一利润丰厚的市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142742","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142742?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:09","pubTimestamp":1790082578,"startTime":"0","endTime":"0","summary":"数据简报-随着竞争日趋激烈,减肥药开发商纷纷抢占这一利润丰厚的市场更新发稿日期,补充罗氏和Viking Therapeutics提供的最新减肥药临床试验数据路透9月22日-减肥药市场正蓬勃发展,生物技术公司竞相争夺这一由诺和诺德和礼来主导的快速增长领域的市场份额。在其中一项试验中,该药物帮助超重患者减重22.7%,低于诺和诺德25%的预期。辉瑞表示,其目标是在2028年获得快速增长的减肥药市场中的首次批准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL4S45E0UX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01093","OZEM","GPCR","VKTX","MTSR","IBRN","GDOC","03145","PPH","VHT","KURE","MRK","KLRA","03692","WDNA","SUHJY","BIB","LLYZ","IBBQ","80016","CURE","ELIL","03121","IBB","TBXU","MEDX","AZN.UK","03933","BBH","PAWZ","THNR","LLYX","02105","00016","CANC","OPK","FHLC","HRTS","PBE","SRRK","FTXH","PFE","ALT","AMGN","IXJ","JDOC","TRUH","LLY","AGNG","LLII"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669114208","title":"安进股价盘前大涨逾4%,受第三期临床试验结果提振。","url":"https://stock-news.laohu8.com/highlight/detail?id=2669114208","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669114208?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:07","pubTimestamp":1790082475,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MRNY","XPH","XBIX","LU0109394709.USD","FTXH","AMGN","HELX","PBE","BBH","MRNX","PPH","CANC","BBP","AZNH","IBBQ","BK4585","RXL","LU2272731865.HKD","PBPH","SYNB","BME","GNOM","TBXU","IBRN","FBT","BIB","LU1992135472.HKD","LU2272731782.SGD","IEHS","LU2473716301.USD","LU2242646821.SGD","RSPH","WDNA","IE00B5TLWC47.USD","BIOY","BK4599","IE00B4R5TH58.HKD","LFSC","IEIH","PJP","IBB","LU0058720904.USD","MEDI","TMED","PSCH","LU0122379950.USD","SBIO","LU0320765992.SGD","IDNA","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198157419","title":"福泰制药宣布Inaxaplin在特定AMKD患者群体中取得积极结果,第13周UACR显著降低42.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1198157419","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198157419?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:06","pubTimestamp":1790082369,"startTime":"0","endTime":"0","summary":"路透社9月22日消息——福泰制药 今日发布重大公告,披露其在APOL1介导肾病额外患者群体中开展的2b期AMPLIFIED研究取得积极成果。详细数据显示,对于伴有中度蛋白尿的AMKD患者,Inaxaplin在治疗第13周时使尿白蛋白肌酐比较基线下降了42.7%。两项研究队列均显示,Inaxaplin总体安全性和耐受性良好,未出现意外安全信号。值得注意的是,这是福泰制药在这两个特定亚群中首次公布Inaxaplin的临床数据,进一步拓展了该药物在AMKD治疗领域的潜在应用范围。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2456880835.USD","IE00B2B36J28.USD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","LU0234570918.USD","LU0889565916.HKD","LU2468319806.SGD","LU0061475181.USD","VRTX","BBH","GNMX","LU0320765992.SGD","IE00BFTCPJ56.SGD","LU1093756325.SGD","LU2237438978.USD","LU0079474960.USD","LU0256863811.USD","PBE","IE00B894F039.SGD","BK4585","LU0823416689.USD","LU1093756168.USD","LU0432979614.USD","LU2324357040.USD","IBB","LU0289739699.SGD","LU1674673428.USD","LU1069344957.HKD","LU2236285917.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","IBBQ","SG9999013999.USD","IE00B19Z3581.USD","SG9999001176.SGD","LU2362540622.SGD","LU1585245621.USD","TBXU","BK4567","IE0002270589.USD","LU2089984988.USD","LU1778281490.HKD","IE00BZ9MQY76.HKD","LU0058720904.USD","LU2362541273.HKD","SG9999001176.USD","LU0109394709.USD","LU1674673691.USD","BK4533","SGXZ57979304.SGD","LU2417539215.USD","IE00BJT1NW94.SGD","BK4532","BIB","IDNA","LU2462157665.USD","LU2362541513.USD","BK4588","LU1035775433.USD","LU1430594728.SGD","BK4139","IE00B19Z3B42.SGD","LU0417517546.SGD","IE00B19Z9P08.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167058424","title":"安进宣布Dazodalibep治疗中重度系统性干燥综合征的3期临床试验取得积极顶线结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1167058424","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167058424?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 21:04","pubTimestamp":1790082253,"startTime":"0","endTime":"0","summary":"安进公司今日发布重磅消息:其研发的Dazodalibep在针对中重度系统性干燥综合征的3期临床试验中,交出了一份令人振奋的答卷。这项研究聚焦于那些饱受病痛折磨的患者群体,而试验数据无疑为这片治疗荒漠带来了希望的甘霖。结果显示,与安慰剂组相比,接受Dazodalibep治疗的患者在关键疗效指标上均实现了统计学意义上的显著改善。分析人士指出,该药物的成功若能在后续环节得以延续,其市场潜力不容小觑,或将重新定义干燥综合征的治疗格局。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","LU1023059063.AUD","PBE","LU2242652126.USD","LU1571399168.USD","IE0009355771.USD","LU1983299246.USD","LU0889565916.HKD","LU2468319806.SGD","PJP","LU0320765992.SGD","BK4139","BK4581","IE00BFTCPJ56.SGD","LU0058720904.USD","BBH","LU0289739699.SGD","LU2112291526.USD","AMGN","SG9999001440.SGD","LU1057294990.SGD","LU2242646821.SGD","BK4534","TBXU","BK4566","IE0002141913.USD","LU0868494617.USD","IE00BJJMRZ35.SGD","BK4588","IE00BJT1NW94.SGD","BK4599","LU0109394709.USD","BK4585","LU1061106388.HKD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU2089984988.USD","BK4533","BIB","LU0122379950.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}